Sean M Grimmond

18PUBLICATIONS
211CO-AUTHORS
Molecular targetsCancer geneticsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Sep 11, 2025
Effects of CVA21, an Oncolytic Virus, in Combination with Pembrolizumab on Immunogenicity and the Tumor Microenvironment in Advanced NSCLC: A Phase I/II Trial.

Adithya Balasubramanian, Claire Marceaux, Sehrish Kanwal

|Aug 21, 2025
Perioperative IDH inhibition in treatment-naive IDH-mutant glioma: a pilot trial.

Katharine J Drummond, Montana Spiteri, Sarah A Cain

|May 20, 2025
Whole genome sequencing improves tissue-of-origin diagnosis and treatment options for cancer of unknown primary.

Richard J Rebello, Atara Posner, Ruining Dong

|Feb 27, 2025
Neoadjuvant triplet immune checkpoint blockade in newly diagnosed glioblastoma.

Georgina V Long, Elena Shklovskaya, Laveniya Satgunaseelan

|Nov 14, 2024
Unravelling mutational signatures with plasma circulating tumour DNA.

Sebastian Hollizeck, Ning Wang, Stephen Q Wong

Pageof 3